Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

ARS Pharma Wins China Approval for Nasal Epinephrine, Secures Milestone Payment

ARS Pharmaceuticals (NASDAQ:SPRY) said China’s drug regulator has approved neffy 2 mg, an epinephrine nasal spray, for the emergency treatment of Type 1 allergic reactions in adults and children weighing at least 30 kilograms, marking the first epinephrine product authorized for community use in the country.

Leia mais: ARS Pharma Wins China Approval for Nasal Epinephrine, Secures Milestone Payment